Vaccine Responsiveness After CAR-T Cell Therapy
NCT04410900
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
B-Cell Neoplasm
Interventions
BIOLOGICAL:
Wistar Rabies Virus Strain PM-1503-3M Vaccine
PROCEDURE:
Biospecimen Collection
Sponsor
Fred Hutchinson Cancer Center